|
|
Volumn 256, Issue 5058, 1992, Pages 808-813
|
|
Human gene therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENOSINE DEAMINASE;
ARTICLE;
CANCER;
ETHICS;
GENE THERAPY;
GENETIC DISORDER;
GENETIC ENGINEERING;
HUMAN;
PRIORITY JOURNAL;
ANALYTICAL APPROACH;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CANCER;
FEDERAL GOVERNMENT;
FUTURE GENERATIONS;
GENETIC DISORDERS;
GENETICS AND REPRODUCTION;
GOVERNMENT REGULATION;
NATIONAL INSTITUTES OF HEALTH;
RISKS AND BENEFITS;
SOCIAL IMPACT;
UNITED STATES;
ADENOSINE DEAMINASE;
BIOETHICS;
CLINICAL TRIALS;
FEMALE;
GENE THERAPY;
GENETIC DISEASES, INBORN;
GENETIC ENGINEERING;
HUMAN;
MALE;
NEOPLASMS;
SAFETY;
|
|
EID: 0026530097
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.1589762 Document Type: Review |
|
Times cited : (717)
|
|
References (0)
|
